Skip to main content
. 2021 Aug 23;90(4):627–639. doi: 10.1002/ana.26172

TABLE 1.

Characteristics of Included Cases with Cerebral and Central Nervous System Events within 31 days from Covid‐19 Vaccination

Characteristics Cerebral Venous Thrombosis (N=45) Ischemic Stroke (N=9) Hemorrhagic Stroke (N=4) Other (N=4) Total (N=62)
Age
Mean (SD) 44.3 (17.0) 55.6 (17.9) 42.8 (13.2) 57.2 (12.9) 46.7 (17.1)
Median 43 56 47 59.5 46
Range 20.0–89.0 31.0–82.0 24.0–53.0 41.0–69.0 20.0–89.0
Age category
<60 36 (80.0%) 6 (66.7%) 4 (100.0%) 2 (50.0%) 48 (77.4%)
60+ 9 (20.0%) 3 (33.3%) 0 (0.0%) 2 (50.0%) 14 (22.6%)
Sex
Female 35 (77.8%) 6 (66.7%) 3 (75.0%) 3 (75.0%) 47 (75.8%)
Male 10 (22.2%) 3 (33.3%) 1 (25.0%) 1 (25.0%) 15 (24.2%)
Smoking
N‐Miss 6 1 2 1 10
Yes 3 (7.7%) 2 (25.0%) 0 (0.0%) 1 (33.3%) 6 (11.5%)
No 36 (92.3%) 6 (75.0%) 2 (100.0%) 2 (66.7%) 46 (88.5%)
Obese
N‐Miss 2 0 0 1 3
No 41 (95.3%) 8 (88.9%) 4 (100.0%) 3 (100.0%) 56 (94.9%)
Yes 2 (4.7%) 1 (11.1%) 0 (0.0%) 0 (0.0%) 3 (5.1%)
History of thrombosis
N‐Miss 2 0 0 1 3
No 42 (97.7%) 9 (100.0%) 4 (100.0%) 3 (100.0%) 58 (98.3%)
Yes 1 (2.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.7%)
Vaccine
ChAdOx1 37 (82.2%) 8 (88.9%) 4 (100.0%) 4 (100.0%) 53 (85.5%)
BNT162b2 8 (17.8%) 1 (11.1%) 0 (0.0%) 0 (0.0%) 9 (14.5%)
mRNA‐1273 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Vaccination Status
First shot 42 (93.3%) 9 (100.0%) 4 (100.0%) 4 (100.0%) 59 (95.2%)
Second shot 3 (6.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (4.8%)